Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage - PubMed (original) (raw)
Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage
M Mayne et al. Stroke. 2001 Jan.
Abstract
Background and purpose: Tumor necrosis factor-alpha (TNF-alpha) expression is increased in brain after cerebral ischemia, although little is known about its abundance and role in intracerebral hemorrhage (ICH). A TNF-alpha-specific antisense oligodeoxynucleotide (ORF4-PE) was used to study the extent to which TNF-alpha expression influenced neurobehavioral outcomes and brain damage in a collagenase-induced ICH model in rat.
Methods: Male Sprague-Dawley rats were anesthetized, and ICH was induced by intrastriatal administration of heparin and collagenase. Immediately before or 3 hours after ICH induction, ORF4-PE was administered directly into the site of ICH. TNF-alpha mRNA and protein levels were measured by reverse transcriptase-polymerase chain reaction and immunoblot analyses. Cell death was measured by terminal deoxynucleotidyl transferase-mediated uridine 5'triphosphate-biotin nick end labeling (TUNEL). Neurobehavioral deficits were measured for 4 weeks after ICH.
Results: ICH induction (n=6) elevated TNF-alpha mRNA and protein levels (P:<0.01) at 24 hours after the onset of injury compared with sham controls (n=6). Immunohistochemical labeling indicated that ICH was accompanied by elevated expression of TNF-alpha in neutrophils, macrophages, and microglia. Administration of ORF4-PE (2.0 nmol) directly into striatal parenchyma, 15 minutes before (n=4) or 3 hours after (n=6) ICH, decreased levels of TNF-alpha mRNA (P:<0.001) and protein (P:<0. 01) in the brain tissue surrounding the hematoma compared with animals treated with saline alone (n=6). Mean+/-SEM striatal cell death (cells per high-powered field) was also reduced in animals receiving ORF4-PE (34.1+/-5.0) compared with the saline-treated ICH group (80.3+/-7.50) (P:<0.001). ORF4-PE treatment improved neurobehavioral deficits observed at 24 hours (P:<0.001) after induction of ICH (n=6) compared with the untreated ICH group (n=6). This improvement was maintained at 28 days after hemorrhage induction (P:<0.001).
Conclusions: These results indicate a pathogenic role for TNF-alpha during ICH and demonstrate that reducing TNF-alpha expression using antisense oligodeoxynucleotides is neuroprotective.
Similar articles
- Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat.
Peeling J, Yan HJ, Corbett D, Xue M, Del Bigio MR. Peeling J, et al. Exp Neurol. 2001 Feb;167(2):341-7. doi: 10.1006/exnr.2000.7564. Exp Neurol. 2001. PMID: 11161622 - Neuroprotective effects of hydrogen inhalation in an experimental rat intracerebral hemorrhage model.
Choi KS, Kim HJ, Do SH, Hwang SJ, Yi HJ. Choi KS, et al. Brain Res Bull. 2018 Sep;142:122-128. doi: 10.1016/j.brainresbull.2018.07.006. Epub 2018 Jul 18. Brain Res Bull. 2018. PMID: 30016724 - Lithium posttreatment confers neuroprotection through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats.
Zheng J, Liu Z, Li W, Tang J, Zhang D, Tang X. Zheng J, et al. J Neurosurg. 2017 Oct;127(4):716-724. doi: 10.3171/2016.7.JNS152995. Epub 2016 Oct 14. J Neurosurg. 2017. PMID: 27739937 - Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage.
Hwang BY, Appelboom G, Ayer A, Kellner CP, Kotchetkov IS, Gigante PR, Haque R, Kellner M, Connolly ES. Hwang BY, et al. Cerebrovasc Dis. 2011;31(3):211-22. doi: 10.1159/000321870. Epub 2010 Dec 21. Cerebrovasc Dis. 2011. PMID: 21178344 Free PMC article. Review. - Exploring neuroprotective drug therapies for intracerebral hemorrhage.
Katsuki H. Katsuki H. J Pharmacol Sci. 2010;114(4):366-78. doi: 10.1254/jphs.10r05cr. Epub 2010 Nov 11. J Pharmacol Sci. 2010. PMID: 21081835 Review.
Cited by
- The TNFα-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss.
Pettigrew LC, Kryscio RJ, Norris CM. Pettigrew LC, et al. PLoS One. 2016 May 4;11(5):e0154721. doi: 10.1371/journal.pone.0154721. eCollection 2016. PLoS One. 2016. PMID: 27144978 Free PMC article. - Gr1+ Macrophages and Dendritic Cells Dominate the Inflammatory Infiltrate 12 Hours After Experimental Intracerebral Hemorrhage.
Hammond MD, Ai Y, Sansing LH. Hammond MD, et al. Transl Stroke Res. 2012 Jul;3(1):s125-s131. doi: 10.1007/s12975-012-0174-9. Transl Stroke Res. 2012. PMID: 23259009 Free PMC article. - Increased perihematomal neuron autophagy and plasma thrombin-antithrombin levels in patients with intracerebral hemorrhage: An observational study.
Wu C, Yan X, Liao Y, Liao L, Huang S, Zuo Q, Zhou L, Gao L, Wang Y, Lin J, Li S, Wang K, Ge X, Song H, Yang R, Lu F. Wu C, et al. Medicine (Baltimore). 2019 Sep;98(39):e17130. doi: 10.1097/MD.0000000000017130. Medicine (Baltimore). 2019. PMID: 31574813 Free PMC article. - Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.
Vinukonda G, Csiszar A, Hu F, Dummula K, Pandey NK, Zia MT, Ferreri NR, Ungvari Z, LaGamma EF, Ballabh P. Vinukonda G, et al. Brain. 2010 Aug;133(Pt 8):2264-80. doi: 10.1093/brain/awq107. Epub 2010 May 20. Brain. 2010. PMID: 20488889 Free PMC article. - Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice.
King MD, McCracken DJ, Wade FM, Meiler SE, Alleyne CH Jr, Dhandapani KM. King MD, et al. J Neurosurg. 2011 Jul;115(1):116-23. doi: 10.3171/2011.2.JNS10784. Epub 2011 Mar 18. J Neurosurg. 2011. PMID: 21417704 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources